Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Jun 16;288(6433):1788–1790. doi: 10.1136/bmj.288.6433.1788

Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise.

N R Peden, R J Dow, T E Isles, B T Martin
PMCID: PMC1441856  PMID: 6145480

Abstract

During a randomised placebo controlled trial of the effects of nadolol in hypertensive patients serum lipid profiles were obtained while the patients were fasting and during and after a meal and an exercise test. Treatment with nadolol was associated with a significant reduction in high density lipoprotein cholesterol at all time points. Serum triglyceride concentrations during treatment with nadolol were higher in the fasting state, though not significantly so, increased further postprandially, and were significantly higher during and after exercise. The changes in high density lipoprotein cholesterol and triglyceride concentrations during beta adrenoceptor blockade may be secondary to a reduction in lipoprotein lipase activity.

Full text

PDF
1788

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  2. Ballantyne D., Ballantyne F. C., McMurdo Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins. Atherosclerosis. 1981 Jun;39(3):301–306. doi: 10.1016/0021-9150(81)90016-2. [DOI] [PubMed] [Google Scholar]
  3. Barboriak J. J., Friedberg H. D. Propranolol and hypertriglyceridemia. Atherosclerosis. 1973 Jan-Feb;17(1):31–35. doi: 10.1016/0021-9150(73)90132-9. [DOI] [PubMed] [Google Scholar]
  4. Bauer J. H., Brooks C. S., Weinstein I., Wilcox H. H., Heimberg M., Burch R. N., Barkley R. Effects of diuretic and propranolol on plasma lipoprotein lipids. Clin Pharmacol Ther. 1981 Jul;30(1):35–43. doi: 10.1038/clpt.1981.124. [DOI] [PubMed] [Google Scholar]
  5. Birnbaum J., DiBianco R., Becker K. L., Muesing R., Costello R. B., Singh S. N., Gottdiener J. S., Fletcher R. D. Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients. Clin Pharmacol Ther. 1983 Mar;33(3):294–300. doi: 10.1038/clpt.1983.36. [DOI] [PubMed] [Google Scholar]
  6. Bloom S. R., Johnson R. H., Park D. M., Rennie M. J., Sulaiman W. R. Differences in the metabolic and hormonal response to exercise between racing cyclists and untrained individuals. J Physiol. 1976 Jun;258(1):1–18. doi: 10.1113/jphysiol.1976.sp011403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973 May;19(5):476–482. [PubMed] [Google Scholar]
  8. Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970 Nov;11(6):583–595. [PubMed] [Google Scholar]
  9. Day J. L., Metcalfe J., Simpson C. N. Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J (Clin Res Ed) 1982 Apr 17;284(6323):1145–1148. doi: 10.1136/bmj.284.6323.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Day J. L., Simpson N., Metcalfe J., Page R. L. Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Br Med J. 1979 Jan 13;1(6156):77–80. doi: 10.1136/bmj.1.6156.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  12. Gibbons D. O., Lant A. F., Ashford A., Collins R. F., Pinder S. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline. Br J Clin Pharmacol. 1976 Feb;3(1):177–184. doi: 10.1111/j.1365-2125.1976.tb00586.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hooper P. L., Woo W., Visconti L., Pathak D. R. Terbutaline raises high-density-lipoprotein-cholesterol levels. N Engl J Med. 1981 Dec 10;305(24):1455–1457. doi: 10.1056/NEJM198112103052406. [DOI] [PubMed] [Google Scholar]
  15. Huttunen J. K., Ehnholm C., Kekki M., Nikkilä E. A. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med. 1976 Apr;50(4):249–260. doi: 10.1042/cs0500249. [DOI] [PubMed] [Google Scholar]
  16. Ivashkiv E. Fluorometric determination of nadolol in human serum and urine. J Pharm Sci. 1977 Aug;66(8):1168–1172. doi: 10.1002/jps.2600660831. [DOI] [PubMed] [Google Scholar]
  17. Kristensen B. O. Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins. Br Med J (Clin Res Ed) 1981 Jul 18;283(6285):191–192. doi: 10.1136/bmj.283.6285.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lennon D. L., Stratman F. W., Shrago E., Nagle F. J., Hanson P. G., Madden M., Spennetta T. Total cholesterol and HDL-cholesterol changes during acute, moderate-intensity exercise in men and women. Metabolism. 1983 Mar;32(3):244–249. doi: 10.1016/0026-0495(83)90188-9. [DOI] [PubMed] [Google Scholar]
  19. Leren P., Foss P. O., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet. 1980 Jul 5;2(8184):4–6. doi: 10.1016/s0140-6736(80)92888-3. [DOI] [PubMed] [Google Scholar]
  20. Lewis B. The lipoproteins: predictors, protectors, and pathogens. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1161–1164. doi: 10.1136/bmj.287.6400.1161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lithell H., Cedermark M., Fröberg J., Tesch P., Karlsson J. Increase of lipoprotein-lipase activity in skeletal muscle during heavy exercise. Relation to epinephrine excretion. Metabolism. 1981 Nov;30(11):1130–1134. doi: 10.1016/0026-0495(81)90059-7. [DOI] [PubMed] [Google Scholar]
  22. Nilsson A., Hansson B. G., Hökfelt B. Effect of metoprolol on blood glycerol, free fatty acids, triglycerides and glucose in relation to plasma catecholamines in hypertensive patients at rest and following submaximal work. Eur J Clin Pharmacol. 1978 Mar 17;13(1):5–8. doi: 10.1007/BF00606673. [DOI] [PubMed] [Google Scholar]
  23. Pinter E. J., Pattee C. J. Effect of beta-adrenergic blockade on resting and stimulated fat mobilization. J Clin Endocrinol Metab. 1967 Oct;27(10):1441–1450. doi: 10.1210/jcem-27-10-1441. [DOI] [PubMed] [Google Scholar]
  24. Tanaka N., Sakaguchi S., Oshige K., Niimura T., Kanehisa T. Effect of chronic administration of propranolol on lipoprotein composition. Metabolism. 1976 Oct;25(10):1071–1075. doi: 10.1016/0026-0495(76)90014-7. [DOI] [PubMed] [Google Scholar]
  25. Waal-Manning H. J. Metabolic effects of beta-adrenoreceptor blockers. Drugs. 1976;11(Suppl 1):121–126. doi: 10.2165/00003495-197600111-00027. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES